mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |